Hayley Lewis - 04 Jun 2021 Form 4 Insider Report for Zosano Pharma Corp

Reporting relationship: Senior Vice President, Operations
Issuer ticker: N/A
Reported as of: 04 Jun 2021
Net transaction value: -$1,376
SEC form: 4
Accepted by SEC: 07 Jun 2021, 18:43:23 UTC
Source filing: View source filing
Reporting owner signature: /s/ Steven Lo, Attorney-in-Fact for Hayley Lewis

Key filing fact

Hayley Lewis filed Form 4 for Zosano Pharma Corp on 07 Jun 2021.

Key facts

This page summarizes Hayley Lewis's Form 4 filing for Zosano Pharma Corp.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2021, 18:43.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$1,376.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZSAN transaction

Common Stock

Sale

Transaction value: $1,376
Shares: -1,709
Change %: -3.3%
Price: $0.8050^*
Shares after: 49,779
Date: 04 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units of the Issuer.

SEC remarks

Senior Vice President, Operations